2026-07-08 · diabetes prevention, DPP, prediabetes, type 2 diabetes prevention, lifestyle medicine, Medicare MDPP · 15 min read

What is the Diabetes Prevention Program (DPP)?

The Diabetes Prevention Program was a US National Institutes of Health randomized controlled trial published in 2002 that enrolled 3,234 adults with prediabetes and compared three arms: an intensive lifestyle intervention aimed at 7% body-weight loss and 150 minutes/week of moderate activity, metformin 850 mg twice daily, and placebo (Knowler 2002, NEJM). Over an average of 2.8 years, the lifestyle arm cut the incidence of type 2 diabetes by 58% versus placebo; metformin cut it by 31%. Today, the term also refers to the CDC's National Diabetes Prevention Program (National DPP) — a network of CDC-recognized in-person, online, and telephonic curricula that deliver the same 16-session lifestyle program to community and clinical populations across the United States.

Does the DPP actually work — or is this old data?

It works, and the durability is unusually well-documented. The DPP Outcomes Study (DPPOS) followed the original participants for more than 15 years: at 10-year follow-up, the intensive lifestyle arm still had 34% lower cumulative diabetes incidence than placebo, and metformin retained about an 18% reduction (DPP Research Group 2009, Lancet). At 15 years, the lifestyle benefit persisted, and even participants who developed diabetes did so with a delay of several years on average (DPP Research Group 2015, Lancet Diabetes Endocrinol). The Finnish Diabetes Prevention Study (Tuomilehto 2001) and China Da Qing 20-year follow-up (Li 2008) show the same signal in independent populations.

How much weight loss is required for the DPP standard to work?

7% of starting body weight is the trial-tested target — about 14 lb for a 200-lb adult. In the original DPP, each 1 kg of weight lost was associated with a 16% reduction in diabetes risk. Larger losses did more, but 7% was the threshold that delivered the 58% risk reduction with the standard curriculum. This is important framing: you do not need 15% or 20% body-weight loss (the numbers modern GLP-1 medications now produce) to prevent diabetes. 7% remains the standard because it is the number the standard is built on.

Does Medicare cover the Diabetes Prevention Program?

Yes. Since 2018, Medicare Part B covers the Medicare Diabetes Prevention Program (MDPP) as a preventive service for eligible beneficiaries with prediabetes — no copay, no deductible when delivered by a recognized MDPP supplier. Eligibility requires an A1c of 5.7–6.4%, a fasting plasma glucose of 110–125 mg/dL, or a 2-hour oral glucose tolerance test of 140–199 mg/dL, along with a BMI of at least 25 (23 for Asian Americans) and no prior diagnosis of type 1 or type 2 diabetes. Most commercial insurers cover the CDC-recognized National DPP as well; state Medicaid coverage varies. Check coverage before paying cash — the recognized curricula are the same whether you pay or your insurer does.

Online-only DPP versus in-person — is one better?

For most people they perform similarly. The CDC recognizes in-person, online, and telephonic delivery formats, and each must meet the same outcome standards to keep recognition. Sepah 2015 (Omada) and Michaelides 2016 (Noom-recognized) showed clinically meaningful weight loss and lifestyle change from digital DPP programs; Ma 2013 (E-LITE, JAMA Intern Med) showed similar outcomes in primary-care-embedded DPP. The right choice is usually the delivery format you will actually complete — the 16-session dose is the active ingredient, not the room it happens in.

Metformin versus DPP lifestyle — which is better?

Lifestyle beats metformin roughly two to one for diabetes prevention. In the original DPP, the intensive lifestyle arm delivered a 58% risk reduction; metformin delivered 31%. At 10-year DPPOS follow-up, lifestyle retained a 34% reduction and metformin retained 18%. Metformin is a reasonable adjunct when lifestyle change is difficult to sustain, and it is the preferred pharmacologic option for prediabetes in adults under 60 with BMI ≥ 35, women with a history of gestational diabetes, or people with rising A1c despite lifestyle work (ADA 2024 Standards of Care Section 3). Lifestyle change is not replaced by metformin — it is added to it.

GLP-1 medications like Wegovy and Ozempic — do they replace the DPP?

No. GLP-1 receptor agonists produce larger weight loss (12–22% of body weight) than the DPP-ILS (~7%) and reduce progression to type 2 diabetes when used for obesity, but the evidence base for the DPP curriculum is broader, longer, and cheaper. In practice the two are additive: a person on semaglutide or tirzepatide who also completes a DPP curriculum builds behavioral and nutrition skills that reduce rebound weight regain if the drug is stopped, and the National DPP is the covered, structured behavioral component of most modern obesity-medicine treatment plans. Skipping the DPP because a GLP-1 is on board is not evidence-supported.

How do I find a CDC-recognized DPP near me?

The CDC maintains a public registry of recognized organizations at cdc.gov/diabetes-prevention. You can filter by ZIP code, delivery format (in-person, online, hybrid, telephonic, distance learning), and recognition status (Pending, Preliminary, Full Plus). If you are on Medicare, filter for MDPP suppliers. If you have commercial insurance, call the member services number on your card and ask for the covered National DPP in-network options; many plans contract with specific providers such as Omada, Noom, Lark, WW's CDC-recognized program, or a local YMCA. If none is convenient, telephonic and distance-learning programs are recognized nationwide.

The Diabetes Prevention Program (DPP): Why the 7% Weight Loss / 150 Minute Standard Still Works 22 Years Later

The Diabetes Prevention Program (DPP) is the landmark US National Institutes of Health trial that established the modern standard for type 2 diabetes prevention. Published in the New England Journal of Medicine in 2002 by Knowler and colleagues, the trial randomized 3,234 adults with prediabetes to an intensive lifestyle intervention (ILS) aimed at 7% body-weight loss and 150 minutes per week of moderate physical activity, metformin 850 mg twice daily, or placebo. Over an average of 2.8 years, the lifestyle arm cut incident type 2 diabetes by 58% versus placebo; metformin cut it by 31% — lifestyle roughly twice as effective as first-line pharmacotherapy for prevention.

More than two decades later, the standard has held. The DPP Outcomes Study (DPPOS) followed the original cohort: at 10 years the lifestyle arm retained a 34% reduction and metformin retained 18% (DPP Research Group 2009, Lancet); at 15 years the benefit persisted and delayed diabetes onset even in participants who eventually progressed (DPP Research Group 2015, Lancet Diabetes and Endocrinology). Independent trials in Finland (Tuomilehto 2001, NEJM) and China (Li 2008, Lancet — Da Qing 20-year follow-up) produced the same signal. Today, the CDC’s National Diabetes Prevention Program (National DPP) delivers the same 16-session curriculum through recognized in-person, online, and telephonic providers, and Medicare Part B has covered the MDPP benefit since 2018.

This guide covers who qualifies, how the four active drivers of the program work, how to enroll, and how DPP compares — and combines — with metformin, GLP-1 medications, and bariatric surgery.

Who this is for — and who it is not for

The DPP is a prevention intervention, not a treatment for established diabetes. It is designed for adults with prediabetes or high risk for prediabetes.

You are generally eligible for a CDC-recognized National DPP or Medicare MDPP if you meet all of the following:

• A1c 5.7–6.4%, or fasting plasma glucose 100–125 mg/dL, or 2-hour OGTT 140–199 mg/dL (110–125 mg/dL FPG for the MDPP-specific threshold), or a documented history of gestational diabetes (GDM)
• BMI ≥ 25 (≥ 23 for Asian Americans, per CDC and MDPP)
• No prior diagnosis of type 1 or type 2 diabetes
• Age ≥ 18 (Medicare MDPP requires age ≥ 65 for beneficiary coverage; the National DPP is age 18+)

The program is not appropriate as a substitute for pharmacotherapy in adults with established type 2 diabetes — see our diabetes and weight loss guide for the T2D framework, and our type 2 diabetes remission via weight loss guide for the DiRECT / DIADEM-I protocols that target reversal (rather than prevention) once diabetes has already been diagnosed. If you have already been diagnosed with T2D, the treatment conversation involves metformin, GLP-1 receptor agonists, SGLT2 inhibitors, and other classes; lifestyle change is layered on top of pharmacotherapy, not used to prevent a condition you already have.

The DPP at a glance — 2002 trial arms and 2026 delivery formats

The four drivers of the DPP protocol

The DPP is not a diet, and it is not an exercise plan — it is a behavior-change curriculum built around four active levers.

1. 7% body-weight loss as the primary lever

In the original trial, each 1 kg of weight lost was associated with a 16% reduction in diabetes risk. Participants who hit the 7% target had the greatest benefit; those who lost less still benefited proportionally. The 7% target is not an all-or-nothing threshold — smaller losses are still meaningful.

2. 150 minutes/week of moderate physical activity

The activity target is 150 minutes per week of moderate-intensity physical activity, most commonly delivered as five 30-minute sessions of brisk walking. There is nothing special about walking versus other moderate-intensity activities, but walking is the modality most participants can sustain — see our walking for weight loss guide for the practical structure. Higher-intensity exercise is not required and does not appear to add measurable benefit for diabetes prevention specifically.

3. Nutrition education (low-fat, calorie-goal-based curriculum)

The DPP nutrition curriculum uses a calorie goal based on starting weight (typically 1200–1800 kcal/day) and a fat-gram target (~25% of calories from fat). The pattern is closer to Mediterranean than to any low-carbohydrate protocol — see our Mediterranean diet for weight loss guide. The nutrition module teaches self-monitoring rather than enforcing a single diet.

4. Group-based accountability and 16 core sessions in year 1

The DPP runs 16 core weekly sessions in the first six months, followed by at least 6 monthly maintenance sessions through year one. Session content covers goal setting, self-monitoring, problem-solving, relapse prevention, and social support — behavior change is the active drug (see our behavioral therapy for weight loss guide). Cohort accountability, peer modeling, and structured feedback translate individual goals into sustained behavior.

Time course — what happens over months, years, and decades

The DPP effect builds over the first year and holds over decades. The table below combines the primary DPP result with the DPPOS long-term follow-ups.

The weight-loss curve fades but the diabetes prevention curve persists — a striking dissociation. Once diabetes has been delayed by several years, later weight regain does not undo the benefit; the risk clock has already been reset for the deferred period.

What the evidence actually shows

DPP primary outcome (Knowler 2002, NEJM). In 3,234 adults with prediabetes, intensive lifestyle intervention cut incident type 2 diabetes by 58% versus placebo; metformin cut it by 31%. Number needed to treat with lifestyle to prevent one case of diabetes over three years was approximately 7.

DPPOS 10- and 15-year follow-up (DPP Research Group 2009, Lancet; 2015, Lancet Diabetes and Endocrinology). At 10 years, the lifestyle arm retained a 34% reduction in cumulative incidence versus placebo; metformin retained 18%. At 15 years the benefit persisted, and even participants who eventually developed diabetes did so several years later on average — a delay that translates into fewer years of microvascular and macrovascular complications.

Da Qing 20-year follow-up (Li 2008, Lancet). In China, a 6-year lifestyle intervention in 577 adults with impaired glucose tolerance produced 43% lower diabetes incidence at 20 years, with later cardiovascular and all-cause mortality signals in extended analyses.

Finnish Diabetes Prevention Study (Tuomilehto 2001, NEJM; Lindström 2013, Diabetologia). In 522 middle-aged Finnish adults with impaired glucose tolerance, individualized lifestyle counseling cut incident diabetes by 58% during a mean 3.2-year intervention, and the 13-year follow-up showed durable reductions consistent with DPPOS.

Cost-effectiveness and community translation (Herman 2005, Ann Intern Med; Ackermann 2008, Am J Prev Med; Ma 2013, JAMA Intern Med). Lifestyle intervention is cost-effective by conventional US thresholds and approaches cost-saving in older adults. DPP delivered through the YMCA (DEPLOY) and primary care (E-LITE) produced meaningful weight loss at a fraction of the trial cost, and Sepah 2015 and Michaelides 2016 extended the translation into digital-first delivery.

How to actually enroll in the National DPP — a 5-step protocol

The National DPP is a covered, structured, standardized curriculum. The five steps below are the practical enrollment path most primary-care and endocrinology clinics use in 2026.

Step 1: Confirm eligibility

Confirm one of the qualifying markers: A1c 5.7–6.4%, fasting plasma glucose 100–125 mg/dL (110–125 for MDPP-specific eligibility), 2-hour OGTT 140–199 mg/dL, or a documented history of gestational diabetes. Confirm BMI ≥ 25 (≥ 23 for Asian Americans). Rule out established type 2 diabetes with a repeat A1c or FPG if any prior value has been in the diabetic range. See our prediabetes and weight loss guide for the fuller diagnostic pathway and our insulin resistance and weight loss guide for the metabolic context.

Step 2: Search the CDC National DPP registry

The CDC maintains a searchable registry of recognized organizations by ZIP code, delivery format, and recognition status (Pending, Preliminary, Full, Full Plus). Filter for delivery format (in-person, online, hybrid, telephonic, distance learning) that fits your schedule. If you are on Medicare, filter specifically for MDPP suppliers.

Step 3: Verify insurance coverage

Under Medicare Part B, the MDPP benefit covers a recognized supplier at no cost-share for eligible beneficiaries. Most commercial insurers contract with specific National DPP providers — Omada, Noom, Lark, WW’s CDC-recognized program, or a local YMCA are common in-network options; call the member services number on your insurance card. State Medicaid coverage varies. See our telehealth weight loss guide for how virtual DPP delivery fits into the broader remote-care landscape.

Step 4: Commit to the full curriculum

Complete 16 weekly core sessions in the first six months and at least 6 monthly maintenance sessions in the following six months. Session attendance is the single strongest predictor of weight loss and diabetes prevention across trial and translation data — participants who attend at least 9 of the 16 core sessions consistently outperform those who attend fewer.

Step 5: Track weight, food, and activity

Every recognized DPP curriculum requires self-monitoring — weight, food, and physical activity, most often through the program’s app or paper logs. The curricula in wide use include PreventT2 (CDC standard curriculum), Group Lifestyle Balance (translation of DPP-ILS used in many YMCA and academic settings), and CDC-recognized digital products from Omada, Noom, Lark, and WW.

Treatment comparison — DPP versus other options

The DPP is one option among several for adults with prediabetes and obesity. The honest comparison places it next to the alternatives.

Special situations

Post-GDM women

Women with a history of gestational diabetes are the highest-risk group in the DPP — roughly 3–7 times baseline risk of progressing to type 2 diabetes. The ILS was particularly effective in this subgroup, and both National DPP and MDPP explicitly qualify GDM history as an eligibility criterion. See our gestational diabetes and weight loss guide.

Age 65 and older

Medicare MDPP is available for eligible beneficiaries with prediabetes. Older adults respond to the curriculum; the response magnitude in the original trial was similar or slightly larger than younger participants.

Metformin non-responders or intolerant

For adults who cannot tolerate metformin or whose A1c is rising despite it, the DPP curriculum is the covered behavioral pillar and can be combined with a GLP-1 receptor agonist depending on BMI and comorbidity.

Prediabetes on antipsychotics or corticosteroids

Prediabetes driven by chronic corticosteroid use or second-generation antipsychotics is complex — the underlying medication often cannot be stopped. DPP still applies, though the weight-loss magnitude may be smaller. Discuss psychiatric medication adjustments with the prescribing clinician.

Prediabetes with obesity (BMI ≥ 30) — where to add a GLP-1

Layering a GLP-1 receptor agonist (Wegovy weight loss or Ozempic for weight loss) on top of a DPP curriculum is increasingly common. The GLP-1 delivers the weight loss; the DPP delivers the behavior and nutrition skills that reduce rebound if the medication is later stopped.

Rural, underserved, and post-bariatric populations

Telephonic and distance-learning DPP formats are CDC-recognized and available nationwide. Adults who develop prediabetes after significant weight regain following bariatric surgery are eligible for the National DPP if they meet the standard criteria and have not been diagnosed with T2D.

Myths and red flags — six things to correct

• “Metformin alone is enough to prevent diabetes.” ILS beat metformin roughly two-to-one in DPP (58% vs 31%) and held that gap at 10 years. Metformin is a useful adjunct; it is not a lifestyle replacement.
• “Prediabetes is not a real diagnosis.” Prediabetes is a well-defined, ADA-standardized risk state with a 5–10% annual progression rate to diabetes and modifiable outcomes (ADA 2024 Standards of Care Section 3).
• “GLP-1 has replaced lifestyle intervention.” GLP-1 medications produce larger short-term weight loss but do not replace the behavioral skills that reduce rebound. DPP + GLP-1 is additive; skipping DPP because a GLP-1 is on board is not evidence-supported.
• “You must lose 15% of body weight to matter.” The DPP standard delivered a 58% risk reduction on a 7% weight-loss target. Larger losses do more, but 7% is the threshold that the standard is built on.
• “Online-only DPP is useless.” Multiple recognized virtual programs (Sepah 2015; Michaelides 2016) show clinically meaningful outcomes. The delivery format that gets completed is the one that works.
• “You need to run marathons.” The activity target is 150 minutes per week of moderate-intensity activity — brisk walking suffices. Higher intensity is not required.

Emergency lines: call 911 for severe hypoglycemia with altered mental status, and call or text 988 (US Suicide and Crisis Lifeline) for behavior-change crisis, disordered eating emergency, or suicidal ideation during any weight-management program.

Bottom line

Two decades after the primary trial published, the Diabetes Prevention Program remains the most durable evidence-based standard for preventing type 2 diabetes. The 7% body-weight loss / 150 minute per week / 16-session curriculum cut incident T2D by 58% in the original DPP, retained a 34% reduction at 10-year DPPOS follow-up, and replicated in Finland and China. The CDC National DPP and Medicare MDPP now deliver the same curriculum through in-person, online, and telephonic providers, and coverage is broadly available. Metformin and GLP-1 medications are additive, not substitutes. If you have prediabetes, enrolling in a recognized DPP is one of the highest-value preventive actions you can take — the standard is the standard because it works.